Bzo-poxizid
CAS: 1048973-64-3
Ref. 3D-YRB97364
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Información del producto
Bzo-poxizid is an anticancer drug that works by inhibiting kinases, proteins that regulate cell growth and division. It targets cancer cells specifically, inducing apoptosis or programmed cell death, which helps to slow down tumor growth. Bzo-poxizid is a potent inhibitor of cyclin-dependent kinases (CDKs), which are enzymes that play a critical role in regulating the cell cycle. The drug has been shown to be effective against various types of cancer in human and Chinese hamster cells. Bzo-poxizid is an analog of urine-derived protein kinase inhibitors and has been found to be effective against both solid tumors and hematological malignancies. This promising cancer treatment has the potential to revolutionize cancer therapy with its unique mechanism of action.
Propiedades químicas
Consulta técnica sobre: 3D-YRB97364 Bzo-poxizid
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
